Status:
COMPLETED
Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting
Lead Sponsor:
Joseph Kim
Collaborating Sponsors:
Alberta Health services
Conditions:
Methicillin-resistant Staphylococcus Aureus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the effectiveness of topical and oral antibiotics in eliminating carriage of methicillin-resistant Staphylococcus aureus (MRSA) among those living in the comm...
Eligibility Criteria
Inclusion
- Prior MRSA infection (i.e index case)
- Identified as being colonized with MRSA on initial screen
Exclusion
- Are pregnant or breastfeeding.
- Have indwelling catheters.
- Received prior decolonization treatment within last 6 months of enrollment.
- Have allergy to study medication.
- Are colonized with MRSA strain resistant to study medication.
- Have active infection requiring systemic antimicrobials.
- Are household contacts to index case.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01232231
Start Date
July 1 2010
End Date
November 1 2012
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Foothills Medical Center
Calgary, Alberta, Canada, T2N 2T9